Tablet-based 'ON/OFF' pathway test can distinguish between rod- and cone-dominated diseases

Amithavikram R Hathibelagal1,2, Phuntsok Bhutia1,2, Mritunjoy Das1,2

  • 1Brien Holden Institute of Optometry and Vision Sciences, L V Prasad Eye Institute, Hyderabad, India.

Abstract

Insights

This study shows that measuring reaction time to light stimuli can help differentiate between rod-dominated and cone-dominated inherited retinal diseases. This tablet-based test offers a new way to diagnose these challenging vision disorders.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Genetics

Background:

  • Photopic ON pathway defects are linked to night vision loss.
  • Measuring ON pathway function to identify rod-dominated diseases remains unexplored.
  • Differentiating between cone- and rod-dominated retinal diseases is crucial for diagnosis.

Purpose of the Study:

  • To evaluate the psychophysical assessment of ON/OFF pathways for distinguishing cone-dominated from rod-dominated retinal diseases.
  • To explore the diagnostic utility of a tablet-based visual function test.

Main Methods:

  • Thirty-seven patients with inherited retinal diseases were tested using the 'EyeSpeed' iPad application.
  • The test involved identifying numbers of light or dark targets on a noise background.
  • Reaction time, accuracy, and performance index were analyzed using receiver-operating characteristic (ROC) analysis.

Main Results:

  • Patients with rod-dominated disease had significantly longer reaction times to light targets (5.28s) compared to cone-dominated disease (2.07s).
  • Reaction time to light targets demonstrated the highest diagnostic ability (Area = 0.89, p < 0.001) among all variables.
  • A criterion of ≥2.98s for reaction time to light targets achieved 82.4% sensitivity and 85% specificity.

Conclusions:

  • Reaction time to light targets, assessed via an ON/OFF pathway paradigm, is a valid marker for differentiating rod- from cone-dominated retinal dystrophies.
  • Tablet-based ON pathway function testing can serve as a supplementary diagnostic tool for photoreceptor-specific inherited retinal diseases.